CXCL8 and neoplasm: Microfluidic droplet-based SERS biosensors has enabled quantification of critical cancer cells secretum including vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) that are indicators of tumor growth and expansion [122].